On Nov. 15, 2017, Novartis announced a partnership with the American Society for Clinical Pathology (ASCP) and the American Cancer Society (ACS) to improve access to cancer treatments and diagnostics in Sub-Saharan Africa (Ethiopia, Uganda, and Tanzania).
Under the terms of the partnershipOriginal Article
